Research Articles
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer
Celeste Leigh Pearce, Mary Anne Rossing, Alice W. Lee, Roberta B. Ness, Penelope M. Webb, Georgia Chenevix-Trench, Susan M. Jordan, Douglas A. Stram, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Marc T. Goodman, Kirsten Moysich, Estrid Hogdall, Allan Jensen, Ellen L. Goode, Brooke L. Fridley, Julie M. Cunningham, Robert A. Vierkant, Rachel Palmieri Weber, Argyrios Ziogas, Hoda Anton-Culver, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Louise Brinton, Nicolas Wentzensen, Jolanta Lissowska, Montserrat Garcia-Closas, Leon F.A.G. Massuger, Lambertus A.L.M. Kiemeney, Anne M. Van Altena, Katja K.H. Aben, Andrew Berchuck, Jennifer A. Doherty, Edwin Iversen, Valerie McGuire, Patricia G. Moorman, Paul Pharoah, Malcolm C. Pike, Harvey Risch, Weiva Sieh, Daniel O. Stram, Kathryn L. Terry, Alice Whittemore, Anna H. Wu, Joellen M. Schildkraut and Susanne K. Kjaer
Celeste Leigh Pearce
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Mary Anne Rossing
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Alice W. Lee
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Roberta B. Ness
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Penelope M. Webb
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Georgia Chenevix-Trench
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Susan M. Jordan
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Douglas A. Stram
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Jenny Chang-Claude
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Rebecca Hein
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Stefan Nickels
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Galina Lurie
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Pamela J. Thompson
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Michael E. Carney
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Marc T. Goodman
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Kirsten Moysich
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Estrid Hogdall
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Allan Jensen
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Ellen L. Goode
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Brooke L. Fridley
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Julie M. Cunningham
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Robert A. Vierkant
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Rachel Palmieri Weber
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Argyrios Ziogas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Hoda Anton-Culver
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Simon A. Gayther
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Aleksandra Gentry-Maharaj
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Usha Menon
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Susan J. Ramus
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Louise Brinton
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Nicolas Wentzensen
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Jolanta Lissowska
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Montserrat Garcia-Closas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Leon F.A.G. Massuger
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Lambertus A.L.M. Kiemeney
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Anne M. Van Altena
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Katja K.H. Aben
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Andrew Berchuck
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Jennifer A. Doherty
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Edwin Iversen
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Valerie McGuire
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Patricia G. Moorman
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Paul Pharoah
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Malcolm C. Pike
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Harvey Risch
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Weiva Sieh
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Daniel O. Stram
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Kathryn L. Terry
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Alice Whittemore
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Anna H. Wu
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Joellen M. Schildkraut
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
Susanne K. Kjaer
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
DOI: 10.1158/1055-9965.EPI-12-1030-T Published May 2013
Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 22, Issue 5, pp. 880-890
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 14, 2012
- Revision received February 15, 2013
- Accepted February 17, 2013
- Published first March 5, 2013.
Article Versions
- Previous version (March 5, 2013 - 09:15).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Celeste Leigh Pearce1,
- Mary Anne Rossing2,
- Alice W. Lee1,
- Roberta B. Ness3,
- Penelope M. Webb,
- for Australian Cancer Study (Ovarian Cancer)4,
- and Australian Ovarian Cancer Study Group4,5,
- Georgia Chenevix-Trench4,
- Susan M. Jordan4,
- Douglas A. Stram1,
- Jenny Chang-Claude6,
- Rebecca Hein6,
- Stefan Nickels6,
- Galina Lurie7,
- Pamela J. Thompson7,
- Michael E. Carney7,
- Marc T. Goodman7,
- Kirsten Moysich8,
- Estrid Hogdall9,
- Allan Jensen9,
- Ellen L. Goode11,
- Brooke L. Fridley11,32,
- Julie M. Cunningham12,
- Robert A. Vierkant11,
- Rachel Palmieri Weber13,
- Argyrios Ziogas17,
- Hoda Anton-Culver17,
- Simon A. Gayther1,18,
- Aleksandra Gentry-Maharaj18,
- Usha Menon18,
- Susan J. Ramus1,18,
- Louise Brinton20,
- Nicolas Wentzensen20,
- Jolanta Lissowska21,
- Montserrat Garcia-Closas19,
- Leon F.A.G. Massuger22,
- Lambertus A.L.M. Kiemeney23,24,25,
- Anne M. Van Altena22,
- Katja K.H. Aben23,25,
- Andrew Berchuck14,
- Jennifer A. Doherty31,
- Edwin Iversen15,
- Valerie McGuire26,
- Patricia G. Moorman13,
- Paul Pharoah27,
- Malcolm C. Pike1,28,
- Harvey Risch29,
- Weiva Sieh26,
- Daniel O. Stram1,
- Kathryn L. Terry30,
- Alice Whittemore26,
- Anna H. Wu1,
- Joellen M. Schildkraut13,16,
- Susanne K. Kjaer9,10,
- for the Ovarian Cancer Association Consortium
- Authors' Affiliations: 1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; 2Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; 3University of Texas, School of Public Health, Houston, Texas; 4Queensland Institute of Medical Research, Brisbane, Australia; 5Peter MacCallum Cancer Centre, East Melbourne, Australia; 6Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; 8Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; 9Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;10Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 11Departments of Health Sciences Research and 12Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; 13Department of Community and Family Medicine, 14Obstetrics and Gynecology, and 15Statistical Science, Duke University; 16Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; 17Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; 18Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;19Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; 20Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 21Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 22Departments of Gynecology, 23Epidemiology, Biostatistics and HTA, and 24Urology, Radboud University Medical Centre, Nijmegen; 25Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; 26Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; 27Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; 28Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; 29Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; 30Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; 31Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and 32Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
- Corresponding Author:
Celeste Leigh Pearce, 1441 Eastlake Avenue, Norris Topping Tower, Room 4417, Los Angeles, CA 90089. Phone: 323-865-0437; Fax: 323-865-0125; E-mail: cpearce{at}usc.edu
May 2013
Volume 22, Issue 5
Volume 22, Issue 5
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer
Celeste Leigh Pearce, Mary Anne Rossing, Alice W. Lee, Roberta B. Ness, Penelope M. Webb, Georgia Chenevix-Trench, Susan M. Jordan, Douglas A. Stram, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Marc T. Goodman, Kirsten Moysich, Estrid Hogdall, Allan Jensen, Ellen L. Goode, Brooke L. Fridley, Julie M. Cunningham, Robert A. Vierkant, Rachel Palmieri Weber, Argyrios Ziogas, Hoda Anton-Culver, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Louise Brinton, Nicolas Wentzensen, Jolanta Lissowska, Montserrat Garcia-Closas, Leon F.A.G. Massuger, Lambertus A.L.M. Kiemeney, Anne M. Van Altena, Katja K.H. Aben, Andrew Berchuck, Jennifer A. Doherty, Edwin Iversen, Valerie McGuire, Patricia G. Moorman, Paul Pharoah, Malcolm C. Pike, Harvey Risch, Weiva Sieh, Daniel O. Stram, Kathryn L. Terry, Alice Whittemore, Anna H. Wu, Joellen M. Schildkraut and Susanne K. Kjaer
Cancer Epidemiol Biomarkers Prev May 1 2013 (22) (5) 880-890; DOI: 10.1158/1055-9965.EPI-12-1030-T
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer
Celeste Leigh Pearce, Mary Anne Rossing, Alice W. Lee, Roberta B. Ness, Penelope M. Webb, Georgia Chenevix-Trench, Susan M. Jordan, Douglas A. Stram, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Marc T. Goodman, Kirsten Moysich, Estrid Hogdall, Allan Jensen, Ellen L. Goode, Brooke L. Fridley, Julie M. Cunningham, Robert A. Vierkant, Rachel Palmieri Weber, Argyrios Ziogas, Hoda Anton-Culver, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Louise Brinton, Nicolas Wentzensen, Jolanta Lissowska, Montserrat Garcia-Closas, Leon F.A.G. Massuger, Lambertus A.L.M. Kiemeney, Anne M. Van Altena, Katja K.H. Aben, Andrew Berchuck, Jennifer A. Doherty, Edwin Iversen, Valerie McGuire, Patricia G. Moorman, Paul Pharoah, Malcolm C. Pike, Harvey Risch, Weiva Sieh, Daniel O. Stram, Kathryn L. Terry, Alice Whittemore, Anna H. Wu, Joellen M. Schildkraut and Susanne K. Kjaer
Cancer Epidemiol Biomarkers Prev May 1 2013 (22) (5) 880-890; DOI: 10.1158/1055-9965.EPI-12-1030-T
Jump to section
Advertisement